Evaluation of inflammatory and biochemical markers in COVID-19 patients treated with tocilizumab alone or with the combination of tocilizumab and convalescent plasma transfusion. (2022). Annals of Medical Research, 29(7), 770-776. http://annalsmedres.org/index.php/aomr/article/view/4231